9 results on '"Renata Glazar"'
Search Results
2. Functional analysis of novel RUNX2 mutations identified in patients with cleidocranial dysplasia
- Author
-
Ewa Hordyjewska-Kowalczyk, Aleksander Jamsheer, Przemko Tylzanowski, Anna Sowińska-Seidler, Renata Glazar, Magdalena Socha, Anna Kruczek, Ewelina M. Olech, and Anna Latos-Bielenska
- Subjects
Male ,0301 basic medicine ,Protein Conformation ,Mutation, Missense ,Core Binding Factor Alpha 1 Subunit ,030105 genetics & heredity ,Biology ,medicine.disease_cause ,Structure-Activity Relationship ,03 medical and health sciences ,Transactivation ,Genetics ,medicine ,Humans ,Protein Isoforms ,Missense mutation ,Genetic Predisposition to Disease ,Genetics (clinical) ,Mutation ,Cleidocranial Dysplasia ,Infant ,Molecular biology ,Phenotype ,RUNX2 ,030104 developmental biology ,Child, Preschool ,RNA splicing ,Female ,Poland ,Nuclear localization sequence - Abstract
RUNX2 (Runt-related transcription factor 2) is a master regulator of osteoblast differentiation, cartilage and bone development. Pathogenic variants in RUNX2 have been linked to the Cleidocranial dysplasia (CCD), which is characterized by hypoplasia or aplasia of clavicles, delayed fontanelle closure, and dental anomalies. Here, we report 11 unrelated Polish patients with CCD caused by pathogenic alterations located in the Runt domain of RUNX2. In total, we identified eight different intragenic variants, including seven missense and one splicing mutation. Three of them are novel: c.407T>A p.(Leu136Gln), c.480C>G p.(Asn160Lys), c.659C>G p.(Thr220Arg), additional three were not functionally tested: c.391C>T p.(Arg131Cys), c.580+1G>T p.(Lys195_Arg229del), c.652A>G p.(Lys218Glu), and the remaining two: c.568C>T p.(Arg190Trp), c.673C>T p.(Arg225Trp) were previously reported and characterized. The performed transactivation and localization studies provide evidence of decreased transcriptional activity of RUNX2 due to mutations targeting the Runt domain and prove that impairment of nuclear localization signal (NLS) affects the subcellular localization of the protein. Presented data show that pathogenic variants discovered in our patients have a detrimental effect on RUNX2, triggering the CCD phenotype.
- Published
- 2019
- Full Text
- View/download PDF
3. Author response for 'Functional analysis of novel RUNX2 mutations identified in patients with Cleidocranial dysplasia'
- Author
-
Ewa Hordyjewska-Kowalczyk, Ewelina M. Olech, Aleksander Jamsheer, Anna Latos-Bieleńska, Anna SowiŃska‐Seidler, Anna Kruczek, Renata Glazar, Magdalena Socha, and Przemko Tylzanowski
- Subjects
RUNX2 ,Pathology ,medicine.medical_specialty ,Cleidocranial Dysplasia ,business.industry ,Medicine ,In patient ,business ,Functional analysis (psychology) - Published
- 2019
- Full Text
- View/download PDF
4. Expanding the clinical spectrum of the ‘HDAC8-phenotype’ - implications for molecular diagnostics, counseling and risk prediction
- Author
-
Hartmut Engels, Juan Pié, Anna Cereda, Giuseppe Zampino, Diana Braunholz, Jacopo Azzollini, Livia Garavelli, M Stefanova, Tim M. Strom, Erwan Watrin, Frank J. Kaiser, Silvia Russo, Dagmar Wieczorek, Karin Buiting, Barbara Graffmann, Ilaria Parenti, Lidia Larizza, Hermann-Josef Lüdecke, Renata Glazar, Ralf Werner, Maura Masciadri, Jelena Pozojevic, Cristina Gervasini, Feliciano J. Ramos, Milena Mariani, Jolanta Wierzba, Kerstin S. Wendt, Angelo Selicorni, and Gabriele Gillessen-Kaesbach
- Subjects
0301 basic medicine ,medicine.medical_specialty ,Cornelia de Lange Syndrome ,Genetic counseling ,NIPBL ,Biology ,SMC1A ,Molecular diagnostics ,medicine.disease ,Bioinformatics ,Phenotype ,3. Good health ,03 medical and health sciences ,030104 developmental biology ,Cohort ,Genetics ,medicine ,Medical genetics ,Genetics (clinical) - Abstract
Cornelia de Lange syndrome (CdLS) is a clinically heterogeneous disorder characterized by typical facial dysmorphism, cognitive impairment and multiple congenital anomalies. Approximately 75% of patients carry a variant in one of the five cohesin-related genes NIPBL, SMC1A, SMC3, RAD21 and HDAC8. Herein we report on the clinical and molecular characterization of 11 patients carrying 10 distinct variants in HDAC8. Given the high number of variants identified so far, we advise sequencing of HDAC8 as an indispensable part of the routine molecular diagnostic for patients with CdLS or CdLS-overlapping features. The phenotype of our patients is very broad, whereas males tend to be more severely affected than females, who instead often present with less canonical CdLS features. The extensive clinical variability observed in the heterozygous females might be at least partially associated with a completely skewed X-inactivation, observed in seven out of eight female patients. Our cohort also includes two affected siblings whose unaffected mother was found to be mosaic for the causative mutation inherited to both affected children. This further supports the urgent need for an integration of highly sensitive sequencing technology to allow an appropriate molecular diagnostic, genetic counseling and risk prediction.
- Published
- 2016
- Full Text
- View/download PDF
5. Rare malformation syndromes in polish registry of congenital malformations in 2014-2017
- Author
-
Anna, Latos-Bielenska, primary, Anna, Materna-Kiryluk, additional, Katarzyna, Wisniewska, additional, Anna, Jamry-Dziurla, additional, Karolina, Matuszewska, additional, Renata, Glazar, additional, Aleksander, Jamsheer, additional, Dorota, Wicher, additional, Ryszard, Slezak, additional, and Jacek, Pilch, additional
- Published
- 2018
- Full Text
- View/download PDF
6. A Mutation in COL9A1 Causes Multiple Epiphyseal Dysplasia: Further Evidence for Locus Heterogeneity
- Author
-
Renata Glazar, Ulpu Seppänen, Tim D. Spector, Liisa Carter, Malwina Czarny-Ratajczak, Anna Latos-Bielenska, Jaana Lohiniva, Jan Królewski, Leena Ala-Kokko, Kazimierz Kozlowski, Piotr Rogala, Merja Perälä, and Lukasz Kolodziej
- Subjects
Male ,Genetic Linkage ,DNA Mutational Analysis ,Cartilage Oligomeric Matrix Protein ,Pseudoachondroplasia ,Locus heterogeneity ,Genetics(clinical) ,Child ,Genetics (clinical) ,Genetics ,Extracellular Matrix Proteins ,Articles ,Middle Aged ,musculoskeletal system ,Pedigree ,Phenotype ,Sulfate Transporters ,Child, Preschool ,Female ,Collagen ,medicine.symptom ,Adult ,musculoskeletal diseases ,Adolescent ,Anion Transport Proteins ,Mutation, Missense ,Biology ,SLC26A2 ,Osteochondrodysplasias ,Collagen Type IX ,Multiple epiphyseal dysplasia ,Genetic Heterogeneity ,medicine ,Humans ,Matrilin Proteins ,Alleles ,Glycoproteins ,Cartilage oligomeric matrix protein ,Polymorphism, Genetic ,Genetic heterogeneity ,Infant ,Membrane Transport Proteins ,medicine.disease ,Osteochondrodysplasia ,Radiography ,Mutation ,biology.protein ,Diastrophic dysplasia ,Carrier Proteins - Abstract
Multiple epiphyseal dysplasia (MED) is an autosomal dominantly inherited chondrodysplasia. It is clinically highly heterogeneous, partially because of its complex genetic background. Mutations in four genes, COL9A2, COL9A3, COMP, and MATR3, all coding for cartilage extracellular matrix components (i.e., the alpha2 and alpha 3 chains of collagen IX, cartilage oligomeric matrix protein, and matrilin-3), have been identified in this disease so far, but no mutations have yet been reported in the third collagen IX gene, COL9A1, which codes for the alpha1(IX) chain. MED with apparently recessive inheritance has been reported in some families. A homozygous R279W mutation was recently found in the diastrophic dysplasia sulfate transporter gene, DTDST, in a patient with MED who had a club foot and double-layered patella. The series consisted of 41 probands with MED, 16 of whom were familial and on 4 of whom linkage analyses were performed. Recombination was observed between COL9A1, COL9A2, COL9A3, and COMP and the MED phenotype in two of the families, and between COL9A2, COL9A3, and COMP and the phenotype in the other two families. Screening of COL9A1 for mutations in the two probands from the families in which this gene was not involved in the recombinations failed to identify any disease-causing mutations. The remaining 37 probands were screened for mutations in all three collagen IX genes and in the COMP gene. The probands with talipes deformities or multipartite patella were also screened for the R279W mutation in DTDST. The analysis resulted in identification of three mutations in COMP and one in COL9A1, but none in the other two collagen IX genes. Two of the probands with a multipartite patella had the homozygous DTDST mutation. The results show that mutations in COL9A1 can cause MED, but they also suggest that mutations in COL9A1, COL9A2, COL9A3, COMP, and DTDST are not the major causes of MED and that there exists at least one additional locus.
- Published
- 2001
- Full Text
- View/download PDF
7. Whole exome sequencing identifies FGF16 nonsense mutations as the cause of X-linked recessive metacarpal 4/5 fusion
- Author
-
Sigmar Stricker, Tomasz Zemojtel, Sandra C. Doelken, Renata Glazar, Aleksander Jamsheer, Mateusz Kolanczyk, Magdalena Socha, Peter Krawitz, Stefan Mundlos, and Jochen Hecht
- Subjects
Male ,Nonsense mutation ,Biology ,DNA sequencing ,Exon ,symbols.namesake ,Genetics ,Humans ,Exome ,Child ,Genetics (clinical) ,Exome sequencing ,X-linked recessive inheritance ,Sanger sequencing ,Genetic Diseases, X-Linked ,Sequence Analysis, DNA ,Metacarpal Bones ,Embryo, Mammalian ,Fibroblast Growth Factors ,Codon, Nonsense ,Organ Specificity ,Mutation (genetic algorithm) ,symbols ,Female ,Hand Deformities, Congenital - Abstract
Background Metacarpal 4–5 fusion (MF4; MIM %309630) is a rare congenital malformation of the hand characterised by the partial or complete fusion of the fourth and fifth metacarpals. The anomaly occurs as an isolated trait or part of a genetic syndrome. Methods To search for disease-causing mutation, whole exome sequencing (WES) was performed on samples from a single trio. Before WES, molecular screening including gene sequencing and array comparative genomic hybridisation was applied. Validation of WES and segregation studies were done using routine Sanger sequencing. Results Exome sequencing detected a nonsense mutation (c.C535T; p.R179X) in exon 3 of the FGF16 gene, which maps to chromosome Xq21.1. Mutational screening of the FGF16 gene performed in an unrelated proband of different ethnicity showed another nonsense mutation in exon 3 (c.C470A; p.S157X). Conclusions This study shows that truncating mutations of FGF16 are associated with X-linked recessive metacarpal 4–5 fusion. The study provides evidence for the involvement of FGF16 in the fine tuning of the human skeleton of the hand.
- Published
- 2013
8. Mutations of NANOS1, a human homologue of the Drosophila morphogen, are associated with a lack of germ cells in testes or severe oligo-astheno-teratozoospermia
- Author
-
Kamila Kusz-Zamelczyk, Maciej Kotecki, Anna Spik, Jadwiga Jaruzelska, Anna Latos-Bielenska, Marcin Sajek, Renata Glazar, Piotr Jedrzejczak, and Leszek Pawelczyk
- Subjects
Infertility ,Male ,Models, Molecular ,medicine.medical_specialty ,Molecular Sequence Data ,Gene mutation ,Biology ,Male infertility ,Mice ,Molecular genetics ,Testis ,Genetics ,medicine ,Animals ,Humans ,Amino Acid Sequence ,Gene ,Genetics (clinical) ,Phylogeny ,Polymorphism, Single-Stranded Conformational ,Azoospermia ,RNA-Binding Proteins ,Molecular Sequence Annotation ,Oligospermia ,Sequence Analysis, DNA ,medicine.disease ,Molecular biology ,Phenotype ,Pedigree ,medicine.anatomical_structure ,Mutation ,Germ cell - Abstract
Background The Nanos gene is a key translational regulator of specific mRNAs involved in Drosophila germ cell development. Disruption of mammalian homologues, Nanos2 or Nanos3 , causes male infertility in mice. In humans, however, no evidence of NANOS2 or NANOS3 mutations causing male infertility has been reported. Although Nanos1 seems dispensable for mouse reproduction, we sought to analyse for the first time its homologue in infertile men. Methods A group of 195 patients manifesting non-obstructive azoospermia or oligozoospermia were tested for mutations of the NANOS1 gene, using single-strand conformation polymorphism and DNA sequencing. Results Three types of NANOS1 gene mutations were identified in five patients and were absent in 800 chromosomes of fertile men. Pedigree analysis indicated a dominant inheritance pattern with penetration limited to males. Two mutations caused deletions of single amino acids, p.Pro77_Ser78delinsPro and p.Ala173del, each of them identified in two unrelated patients. Both types of deletions were located in the NANOS1 N-terminus (responsible for protein interactions) and were associated with a lack of germ cells in testes. Interestingly, the Pro77_Ser78delinsPro mutation altered interaction of NANOS1 with a microRNA biogenesis factor, GEMIN3. The third identified mutation, p.[(Arg246His; Arg276Tyr)], found in the C-terminal RNA-binding domain, was present in a single oligo-astheno-teratozoospermic man. We bioinformatically demonstrated that the p.Arg246His substitution causes a decrease in the positive charge of this domain, potentially altering RNA-binding. Conclusions This is the first report describing the association of NANOS1 gene mutations with human infertility. Two different infertility phenotypes may reflect distinct functions of N-terminal versus C-terminal regions of NANOS1.
- Published
- 2013
9. Frequency of 22q11.2 microdeletion in children with congenital heart defects in western poland
- Author
-
Renata Glazar, Aldona Siwińska, Danuta Wolnik-Brzozowska, Ryszard Słomski, Anna Wozniak, Tomasz Moszura, Anna Latos-Bielenska, Joanna Skołożdrzy, Waldemar Bobkowski, Maciej R Krawczyński, Magdalena Badura-Stronka, Marzena Wisniewska, Joanna Zeyland, and Anna Materna-Kiryluk
- Subjects
Heart Defects, Congenital ,Heart Septal Defects, Ventricular ,Male ,Pediatrics ,medicine.medical_specialty ,Chromosomes, Human, Pair 22 ,Heart Septal Defects, Atrial ,Gene Frequency ,Risk Factors ,Internal medicine ,medicine ,Humans ,Genetic Predisposition to Disease ,Pediatrics, Perinatology, and Child Health ,Child ,Allele frequency ,Tetralogy of Fallot ,Heart septal defect ,medicine.diagnostic_test ,business.industry ,Interrupted aortic arch ,Infant, Newborn ,lcsh:RJ1-570 ,lcsh:Pediatrics ,Microdeletion syndrome ,medicine.disease ,Thymic hypoplasia ,Child, Preschool ,Pediatrics, Perinatology and Child Health ,Chromosomal region ,Cardiology ,Female ,Poland ,Chromosome Deletion ,business ,Fluorescence in situ hybridization ,Research Article - Abstract
Background The 22q11.2 microdeletion syndrome (22q11.2 deletion syndrome -22q11.2DS) refers to congenital abnormalities, including primarily heart defects and facial dysmorphy, thymic hypoplasia, cleft palate and hypocalcaemia. Microdeletion within chromosomal region 22q11.2 constitutes the molecular basis of this syndrome. The 22q11.2 microdeletion syndrome occurs in 1/4000 births. The aim of this study was to determine the frequency of 22q11.2 microdeletion in 87 children suffering from a congenital heart defect (conotruncal or non-conotruncal) coexisting with at least one additional 22q11.2DS feature and to carry out 22q11.2 microdeletion testing of the deleted children's parents. We also attempted to identify the most frequent heart defects in both groups and phenotypic traits of patients with microdeletion to determine selection criteria for at risk patients. Methods The analysis of microdeletions was conducted using fluorescence in situ hybridization (FISH) on metaphase chromosomes and interphase nuclei isolated from venous peripheral blood cultures. A molecular probe (Tuple) specific to the HIRA (TUPLE1, DGCR1) region at 22q11 was used for the hybridisation. Results Microdeletions of 22q11.2 region were detected in 13 children with a congenital heart defect (14.94% of the examined group). Microdeletion of 22q11.2 occurred in 20% and 11.54% of the conotruncal and non-conotruncal groups respectively. Tetralogy of Fallot was the most frequent heart defect in the first group of children with 22q11.2 microdeletion, while ventricular septal defect and atrial septal defect/ventricular septal defect were most frequent in the second group. The microdeletion was also detected in one of the parents of the deleted child (6.25%) without congenital heart defect, but with slight dysmorphism. In the remaining children, 22q11.2 microdeletion originated de novo. Conclusions Patients with 22q11.2DS exhibit wide spectrum of phenotypic characteristics, ranging from discreet to quite strong. The deletion was inherited by one child. Our study suggests that screening for 22q11.2 microdeletion should be performed in children with conotruncal and non-conotruncal heart defects and with at least one typical feature of 22q11.2DS as well as in the deleted children's parents.
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.